| 1. |
|
|
| 2. |
|
|
| 3. |
- Jönsson, Lena M, et al.
(author)
-
A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses.
- 2002
-
In: Journal of Nuclear Medicine. - 0161-5505. ; 43:12, s. 1657-1664
-
Journal article (peer-reviewed)abstract
- Current internal radiation dosimetry models for the small intestine, and for most walled organs, lack the ability to account for the activity uptake in the intestinal wall. In existing models the cross-dose from nearby loops of the small intestine is not taken into consideration. The aim of this investigation was to develop a general model for calculating the absorbed dose to the radiation-sensitive cells in the small intestinal mucosa from radionuclides located in the small intestinal wall or contents. Methods: A model was developed for calculation of the self-dose and cross-dose from activity in the intestinal wall or contents. The small intestine was modeled as a cylinder with 2 different wall thicknesses and with an infinite length. Calculations were performed for various mucus thicknesses. S values were calculated using the EGS4 Monte Carlo simulation package with the PRESTA algorithm and the simulation results were integrated over the depth of the radiosensitive cells. The cross-organ dose was calculated by summing the dose contributions from other intestinal segments. Calculations of S values for self-dose and cross-dose were made for monoenergetic electrons, 0.050–10 MeV, and for the radionuclides 99mTc, 111In, 131I, 67Ga, 90Y, and 211At. Results: The self-dose S value from activity located in the small intestinal wall is considerably greater than the S values for self-dose from the contents and the cross-dose from wall and contents except for high electron energies. For all radionuclides investigated and for electrons 0.10–0.20 MeV and 8–10 MeV in energy, the cross-dose from activity in the contents is higher than the self-dose from the contents. The mucus thickness affects the S value when the activity is located in the contents. Conclusion: A dosimetric model for the small intestine was developed that takes into consideration the localization of the radiopharmaceutical in the intestinal wall or in the contents. It also calculates the contribution from self-dose and cross-dose. With this model, more accurate calculations of absorbed dose to radiation-sensitive cells in the intestine are possible.
|
|
| 4. |
|
|
| 5. |
- Kanatsuna, N, et al.
(author)
-
Doubly reactive INS-IGF2 autoantibodies in children with newly diagnosed autoimmune (type 1) diabetes
- 2015
-
In: Scandinavian Journal of Immunology. - : Wiley-Blackwell. - 0300-9475 .- 1365-3083. ; 82:4, s. 361-369
-
Journal article (peer-reviewed)abstract
- The splice variant INS-IGF2 entails the preproinsulin signal peptide, the insulin B-chain, eight amino acids of the C-peptide and 138 unique amino acids from an ORF in the IGF2 gene. The aim of this study was to determine whether levels of specific INS-IGF2 autoantibodies (INS-IGF2A) were related to age at diagnosis, islet autoantibodies, HLA-DQ or both, in patients and controls with newly diagnosed type 1 diabetes. Patients (n = 676), 0-18 years of age, diagnosed with type 1 diabetes in 1996-2005 and controls (n = 363) were analysed for specific INS-IGF2A after displacement with both cold insulin and INS-IGF2 to correct for non-specific binding and identify double reactive sera. GADA, IA-2A, IAA, ICA, ZnT8RA, ZnT8WA, ZnT8QA and HLA-DQ genotypes were also determined. The median level of specific INS-IGF2A was higher in patients than in controls (P < 0.001). Irrespective of age at diagnosis, 19% (126/676) of the patients had INS-IGF2A when the cut-off was the 95th percentile of the controls (P < 0.001). The risk of INS-IGF2A was increased among HLA-DQ2/8 (OR = 1.509; 95th CI 1.011, 2.252; P = 0.045) but not in 2/2, 2/X, 8/8, 8/X or X/X (X is neither 2 nor 8) patients. The association with HLA-DQ2/8 suggests that this autoantigen may be presented on HLA-DQ trans-heterodimers, rather than cis-heterodimers. Autoantibodies reactive with both insulin and INS-IGF2A at diagnosis support the notion that INS-IGF2 autoimmunity contributes to type 1 diabetes.
|
|
| 6. |
- Knutsen Rydberg, Ellen, 1969, et al.
(author)
-
Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages
- 2004
-
In: Arterioscler Thromb Vasc Biol. ; 24:11, s. 2040-2045
-
Journal article (peer-reviewed)abstract
- OBJECTIVE: Macrophage-mediated oxidation of low-density lipoprotein (LDL) by enzymes, such as the lipoxygenases, is considered of major importance for the formation of oxidized LDL during atherogenesis. Macrophages have been identified in hypoxic areas in atherosclerotic plaques. METHODS AND RESULTS: To investigate the role of hypoxia in macrophage-mediated LDL oxidation, we incubated human monocyte-derived macrophages with LDL under normoxic (21% O2) or hypoxic (0% O2) conditions. The results showed that hypoxic macrophages oxidized LDL to a significantly higher extent than normoxic cells. Interestingly, the mRNA and protein expression of 15-lipoxygenase-2 (15-LOX-2) as well as the activity of this enzyme are elevated in macrophages incubated at hypoxia. Both the unspliced 15-LOX-2 and the spliced variant 15-LOX-2sv-a are found in macrophages. In addition, 15-LOX-2 was identified in carotid plaques in some macrophage-rich areas but was only expressed at low levels in nondiseased arteries. CONCLUSIONS: In summary, these observations show for the first time that 15-LOX-2 is expressed in hypoxic macrophages and in atherosclerotic plaques and suggest that 15-LOX-2 may be one of the factors involved in macrophage-mediated LDL oxidation at hypoxia.
|
|
| 7. |
|
|
| 8. |
- Andersson, C, et al.
(author)
-
The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes
- 2011
-
In: Autoimmunity. - : Taylor & Francis. - 0891-6934 .- 1607-842X. ; 44:5, s. 394-405
-
Journal article (peer-reviewed)abstract
- Aims: We tested whether autoantibodies to all three ZnT8RWQ variants, GAD65, insulinoma-associated protein 2 (IA-2), insulin and autoantibodies to islet cell cytoplasm (ICA) in combination with human leukocyte antigen (HLA) would improve the diagnostic sensitivity of childhood type 1 diabetes by detecting the children who otherwise would have been autoantibody-negative.Methods: A total of 686 patients diagnosed in 1996–2005 in Skåne were analyzed for all the seven autoantibodies [arginin 325 zinc transporter 8 autoantibody (ZnT8RA), tryptophan 325 zinc transporter 8 autoantibody (ZnT8WA), glutamine 325 Zinc transporter 8 autoantibody (ZnT8QA), autoantibodies to glutamic acid decarboxylase (GADA), Autoantibodies to islet-antigen-2 (IA-2A), insulin autoantibodies (IAA) and ICA] in addition to HLA-DQ genotypes.Results: Zinc transporter 8 autoantibody to either one or all three amino acid variants at position 325 (ZnT8RWQA) was found in 65% (449/686) of the patients. The frequency was independent of age at diagnosis. The ZnT8RWQA reduced the frequency of autoantibody-negative patients from 7.5 to 5.4%—a reduction by 28%. Only 2 of 108 (2%) patients who are below 5 years of age had no autoantibody at diagnosis. Diagnosis without any islet autoantibody increased with increasing age at onset. DQA1-B1*X-0604 was associated with both ZnT8RA (p = 0.002) and ZnT8WA (p = 0.01) but not with ZnT8QA (p = 0.07). Kappa agreement analysis showed moderate (>0.40) to fair (>0.20) agreement between pairs of autoantibodies for all combinations of GADA, IA-2A, ZnT8RWQA and ICA but only slight ( < 0.19) agreement for any combination with IAA.Conclusions: This study revealed that (1) the ZnT8RWQA was common, independent of age; (2) multiple autoantibodies were common among the young; (3) DQA1-B1*X-0604 increased the risk for ZnT8RA and ZnT8WA; (4) agreement between autoantibody pairs was common for all combinations except IAA. These results suggest that ZnT8RWQA is a necessary complement to the classification and prediction of childhood type 1 diabetes as well as to randomize the subjects in the prevention and intervention of clinical trials.
|
|
| 9. |
-
Bioblitz i Arkelstorp 16-17 augusti 2019
- 2020
-
Editorial collection (other academic/artistic)abstract
- Arkelstorpsviken är den nordvästra delen av Oppmannasjön, som ären av Skånes största sjöar. Idén att genomföra en så kallad Bioblitzvid Arkelstorpsviken föddes under ett styrelsemöte i projektet "En viki Sjöriket Skåne" som är ett samarbete mellan Oppmanna Vånga Bygderåd och Högskolan Kristianstad. Projektets främsta syfte är att hitta en lösning på den kraftiga övergödningen i Arkelstorpsviken. Detta är ett ”Leader”-finansierat projekt, vilket innebär att stommen i projektetär lokal förankring. Det fanns röster i byn som kände att man gav området onödigt dåligt rykte genom att ständigt lyfta fram problemen med vattenstatusen i sjön. Under ett styrelsemöte 30 sep 2018 föddes iden att genom en Bioblitz lyfta fram de positiva värdena i och kring sjön. Den naturliga samarbetspartnern för detta projekt var forskningsmiljön MABH (Man & Biosphere Health) vid Högskolan Kristianstad,vars medlemmar tillsammans besitter en mycket bred biologisk kunskap.Med MABH i ryggen var alltså kompetensen säkrad för att genomföra en Bioblitz. Inbjudningar skickades ut till lokala naturorganisationerför att hitta ännu fler experter som kunde hjälpa till med särskilda artgrupper. Samtidigt jobbade man aktivt lokalt med att försöka engagera intresserad allmänhet. Inbjudningar och direktreklam skickades ut till samtliga hushåll med postadress Arkelstorp. I ett försök att synas genom mediebruset anordnades en tävling, som gick ut på att gissa antalet arter (taxa) som hittades under Bioblitzen. Två lokala företag ställde upp och första priset för den vuxna individ som gissade närmstvar en 3-rätters måltid på Bäckaskogs Slott. De yngre tävlande kunde vinna en kanotutflykt med familjen på Ivögården.
|
|
| 10. |
- Halbig, Josefine M., et al.
(author)
-
Oral health-related quality of life, impaired physical health and orofacial pain in children and adolescents with juvenile idiopathic arthritis – a prospective multicenter cohort study
- 2023
-
In: BMC Oral Health. - 1472-6831. ; 23:1
-
Journal article (peer-reviewed)abstract
- Background: Knowledge on oral health-related quality of life (OHRQoL) in children and adolescents with juvenile idiopathic arthritis (JIA) is limited, and longitudinal studies are lacking. We aimed to describe OHRQoL in children and adolescents with JIA compared to controls, and to explore the validity and internal consistency of the Early Childhood Oral Health Impact Scale (ECOHIS) and the Child Oral Impact on Daily Performance (Child-OIDP). Furthermore, we wanted to investigate associations between OHRQoL and orofacial pain, physical health, disease activity, and temporomandibular joint (TMJ) involvement in JIA. Methods: The Norwegian prospective, multicenter cohort study recruited participants with JIA between 4 and 16years of age and corresponding controls from three pediatric university hospital departments and public dental health services. In the present study, we analyzed OHRQoL in all children < 12years with the ECOHIS and adolescents ≥ 12years with the Child-OIDP at the first visit and the two-year follow-up. Associations between OHRQoL and JIA characteristics, collected in clinical exam and questionnaires, were analyzed in logistic regressions. Results: The same OHRQoL questionnaire was completed both at first visit and two-year follow-up in 101 children < 12years (47 JIA, 54 controls) and 213 adolescents ≥ 12years (111 JIA, 102 controls). The frequency of OHRQoL impacts in children was similar at the first visit and the two-year follow-up (ECOHIS > 0: JIA group 81% and 85%, p = 0.791; control group 65% and 69%, p = 0.815), while adolescents with JIA reported fewer impacts at the two-year follow-up (Child OIDP > 0: JIA group 27% and 15%, p = 0.004; control group 21% and 14%, p = 0.230). The internal consistency of the OHRQoL instruments was overall acceptable and the criterion validity indicated that the instruments were valid at both visits. Orofacial pain was more frequent in children and adolescents with JIA than in controls. We found associations between OHRQoL impacts and orofacial pain, impaired physical health, disease activity, and TMJ involvement. Conclusions: Children and adolescents with orofacial pain or impaired physical health were more likely to report impacts on daily life activities than those without. Pediatric rheumatologists and dentists should be aware of impaired OHRQoL in individuals with JIA with active disease or temporomandibular joint involvement. Trial registration: Registered on clinicaltrials.gov(NCT03904459, 05/04/2019).
|
|
| 11. |
- Håkansson, Lena, et al.
(author)
-
Effects on in vivo administration of G-CSF on neutrophil and eosinophil adhesion
- 1997
-
In: British Journal of Haematology. - : Wiley. - 0007-1048 .- 1365-2141. ; 98:3, s. 603-611
-
Journal article (peer-reviewed)abstract
- The effect in vivo of G-CSF on neutrophil and eosinophil adhesion was studied after subcutaneous administration to six healthy individuals of human recombinant glycosylated G-CSF (lenograstim) (3 micrograms/kg) for 6 consecutive days. Basal adhesion and adhesion to E-selectin. VCAM-1 and ICAM-1 of neutrophil and eosinophil granulocytes were measured selectively. During G-CSF administration neutrophil basal adhesion increased from 7.4 +/- 3.9% (mean +/- SD) to 55.8 +/- 12.9% and 23.2 +/- 4.4%, 4 and 7 d, respectively, after start of the administration. At the same time points eosinophil basal adhesion increased from 7.1 +/- 2.4% to 37.7 +/- 6.1% and 13.1 +/- 5.3%, respectively. When adhesion was measured in the presence of Mn2+, which increases the functional activity of integrins, an even higher increase of neutrophil and eosinophil basal adhesion was noted 4 and 7 d, respectively, after start of G-CSF administration. In parallel with the enhanced basal adhesion neutrophil adhesion to E-selectin and ICAM-1 and eosinophil adhesion to E-selectin. VCAM-1 and ICAM-1 were significantly (P < 0.05) increased after 4 d of G-CSF administration as was neutrophil cell surface expression of CD11b and CD18. In vitro G-CSF induced minimal changes of granulocyte basal adhesion and inhibition of the adhesion to E-selectin. 10 ng/ml TNF alpha significantly increased neutrophil and eosinophil basal adhesion and adhesion to VCAM-1 and ICAM-1. In summary, administration of G-CSF to healthy subjects induced enhanced adhesion of neutrophil and eosinophil granulocytes, probably mediated by an increase of the functional capacity of beta 1- and beta 2-integrins. The induction of increased levels of TNF alpha might be one mechanism behind the in vivo effect of G-CSF administration.
|
|
| 12. |
- Junghans, Victoria, et al.
(author)
-
Effects of a local auxiliary protein on the two-dimensional affinity of a TCR-peptide MHC interaction
- 2020
-
In: Journal of Cell Science. - : The Company of Biologists Ltd.. - 0021-9533 .- 1477-9137. ; 133:15
-
Journal article (peer-reviewed)abstract
- The affinity of T-cell receptors (TCRs) for major histocompatibility complex molecules (MHCs) presenting cognate antigens likely determines whether T cells initiate immune responses, or not. There exist few measurements of two-dimensional (2D) TCR-MHC interactions, and the effect of auxiliary proteins on binding is unexplored. Here, Jurkat T-cells expressing the MHC molecule HLA-DQ8-glia-α1 and the ligand of an adhesion protein (rat CD2) were allowed to bind supported lipid bilayers (SLBs) presenting fluorescently-labelled L3-12 TCR and rat CD2, allowing measurements of binding unconfounded by cell signaling effects or co-receptor binding. The 2D Kd for L3-12 TCR binding to HLA-DQ8-glia-α1, 14±5 molecules/μm2, was only marginally influenced by including CD2 up to ∼200 bound molecules/μm2 but higher CD2 densities reduced the affinity up to 1.9-fold. Cell-SLB contact size increased steadily with ligand density without affecting binding for contacts up to ∼20% of total cell area but beyond this lamellipodia appeared, giving an apparent increase in bound receptors of up to 50%. Our findings show how parameters other than the specific protein-protein interaction can influence binding behavior at cell-cell contacts.
|
|
| 13. |
|
|
| 14. |
- Jönsson, Lena M, et al.
(author)
-
Evaluation of accuracy in activity calculations for the conjugate view method from monte carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom.
- 2005
-
In: Journal of Nuclear Medicine. - 0161-5505. ; 46:10, s. 1679-1686
-
Journal article (peer-reviewed)abstract
- Activity determination from scintillation camera images using the conjugate view method may be inaccurate because of variation in scattered radiation from adjacent organs and activity from overlapping tissues. The aim of this study was to simulate patient scintillation camera images and from these evaluate the accuracy of 2 correction methods. The contribution from overlapping tissue activity was also calculated for some organs. Methods: Biokinetic data for Tc-99m-sestamibi obtained in rats was used as input to simulate scintillation camera images with a voxel-based computer phantom using the Monte Carlo method. The organ activity was calculated using the conjugate view method with either the effective attenuation coefficient method or scatter correction using the triple-energy window (TEW) method combined with attenuation correction with a transmission factor image. Images were simulated with activity in organs one by one to evaluate the accuracy of the 2 correction methods and to evaluate the activity contribution from activity in adjacent or overlapping tissues. To allow comparison with the clinical situation, the total activity distribution from the animal study was used to simulate scintillation camera images at different points in time and the calculated activity was compared with both the input data and some patient data from the literature. Results: The combination of scatter and attenuation correction gave the most accurate calculated activity, +/- 10% of the true activity from the images with activity in one organ at a time. In the images similar to the clinical situation, the kidney activity was overestimated up to a factor of 34, mainly because of excretion of activity through the intestines. Conclusion: The scatter correction using the TEW method in combination with attenuation correction with the measured transmission factor resulted in the most accurate activity determination of the methods used. This study also shows that organ activity data calculated from scintillation camera images may be overestimated by >90% because of activity in overlapping tissues.
|
|
| 15. |
- Jönsson, Lena M
(author)
-
Internal Dosimetry Development and Evaluation of Methods and Models
- 2007
-
Doctoral thesis (other academic/artistic)abstract
- Radionuclide therapy requires patient-specific planning of the absorbed dose to target volumes, in most cases tumours, in order to achieve an expected biological effect, taking into account that the absorbed doses to normal organs and tissues should be kept as low as reasonably achievable. Therefore, the calculation of absorbed doses has to be as accurate as possible. The accuracy depends on the methods used for activity quantification and on how well the dosimetric model describes the organs and tissues in the particular patient. This thesis presents new methodologies developed to investigate the accuracy of internal dosimetry. The main focus was on the use of detailed biokinetic data from animals combined with Monte Carlo simulations using anthropomorphic phantoms on macro level, and applied in the development and refinement of an intestinal dosimetry model on a small-scale level. A novel approach is the generation of Monte Carlo simulated scintillation camera images of a computer patient using a radionuclide biodistribution obtained from an experimental animal study. The accuracy of the activity quantification based on planar scintillation camera imaging was investigated and in particular the corrections for attenuation and scatter with the presence of activity in overlapping tissues. The absorbed doses were calculated using phantom-specific dose factors (S values) and were compared with absorbed doses calculated from standard MIRD-phantom-based S values. The results demonstrate the potential inaccuracy of the calculated absorbed dose to an individual patient when using dose factors based on the MIRD phantom. A dosimetry model for the small intestine was developed and refined in order to obtain a more accurate model and dose factors. Previous dosimetry models of the small intestine have been limited to calculating the absorbed dose to the intestinal wall from activity in the contents only. The work in this thesis included Monte Carlo calculations of dose factors for the radiation sensitive crypt cells as target organ. The activity in the contents as well as in the intestinal wall was taken into account, and dose factors were calculated for both self-dose and cross-dose from surrounding parts of the small intestine. Calculations of the absorbed dose to the crypt cells for a realistic activity distribution are presented and compared with results from the general absorbed dose calculation. It is evident from the results in this thesis that improvements are necessary in the quantification procedure, as well as further development of more realistic, small-scale anatomy models.
|
|
| 16. |
- Jönsson, Lena M, et al.
(author)
-
Management of Radioactive Waste in Nuclear Medicine
- 2022. - 1
-
In: Handbook of Nuclear Medicine and Molecular Imaging for Physicists : Radiopharmaceuticals and Clinical Applications, Volume III - Radiopharmaceuticals and Clinical Applications, Volume III. - 9781138593312 - 9780429489501 ; 3
-
Book chapter (peer-reviewed)abstract
- The use of radionuclides in medicine will inevitably result in various forms of radioactive waste. The waste emerges from the production of radionuclides and radiopharmaceuticals, diagnostic and therapeutic use, and in biomedical research. Radioactive waste can also include spent sealed sources used for calibration, or quality control of different kind of medical equipment. The waste can lie within a wide range of activities and half-lives and be in different forms, solids, liquids, or airborne. In nuclear medical applications the main part of the radioactive waste consists of radionuclides with short half-life and low radiotoxicity, but other risks associated with the waste must also be considered. The philosophy of all work with radioactive material is to minimize any hazards on human health and impact on the environment both in the short and long term. To meet this, the basic principles of radiation safety must be applied – that is, justification, optimization, and the use of dose limits. This also includes radioactive waste management, and therefore the radioactive waste generated must be kept to a minimum as well as adapted to the work situation. The management of radioactive waste from medical applications is guided by international recommendations and regulated by regional and national authorities. The organization and regulations may vary in different countries due to the national legal framework, but the purpose is the same – to minimize a negative impact of the waste in all aspects.
|
|
| 17. |
|
|
| 18. |
|
|
| 19. |
- Liu, Han, et al.
(author)
-
A multistate modeling and simulation framework to learn dose-response of oncology drugs : Application to bintrafusp alfa in non‐small cell lung cancer
- 2023
-
In: CPT. - : John Wiley & Sons. - 2163-8306. ; 12:11, s. 1738-1750
-
Journal article (peer-reviewed)abstract
- The dose/exposure-efficacy analyses are often conducted separately for oncology end points like best overall response, progression-free survival (PFS) and overall survival (OS). Multistate models offer to bridge these dose-end point relationships by describing transitions and transition times from enrollment to response, progression, and death, and evaluating transition-specific dose effects. This study aims to apply the multistate pharmacometric modeling and simulation framework in a dose optimization setting of bintrafusp alfa, a fusion protein targeting TGF-β and PD-L1. A multistate model with six states (stable disease [SD], response, progression, unknown, dropout, and death) was developed to describe the totality of endpoints data (time to response, PFS, and OS) of 80 patients with non-small cell lung cancer receiving 500 or 1200 mg of bintrafusp alfa. Besides dose, evaluated predictor of transitions include time, demographics, premedication, disease factors, individual clearance derived from a pharmacokinetic model, and tumor dynamic metrics observed or derived from tumor size model. We found that probabilities of progression and death upon progression decreased over time since enrollment. Patients with metastasis at baseline had a higher probability to progress than patients without metastasis had. Despite dose failed to be statistically significant for any individual transition, the combined effect quantified through a model with dose-specific transition estimates was still informative. Simulations predicted a 69.2% probability of at least 1 month longer, and, 55.6% probability of at least 2-months longer median OS from the 1200 mg compared to the 500 mg dose, supporting the selection of 1200 mg for future studies.
|
|
| 20. |
|
|
| 21. |
- Tønnesen, Siren, et al.
(author)
-
Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder : A Multisample Diffusion Tensor Imaging Study
- 2020
-
In: Biological Psychiatry. - : Elsevier BV. - 2451-9022 .- 2451-9030. ; 5:12, s. 1095-1103
-
Journal article (peer-reviewed)abstract
- BACKGROUND: Schizophrenia (SZ) and bipolar disorder (BD) share substantial neurodevelopmental components affecting brain maturation and architecture. This necessitates a dynamic lifespan perspective in which brain aberrations are inferred from deviations from expected lifespan trajectories. We applied machine learning to diffusion tensor imaging (DTI) indices of white matter structure and organization to estimate and compare brain age between patients with SZ, patients with BD, and healthy control (HC) subjects across 10 cohorts.METHODS: We trained 6 cross-validated models using different combinations of DTI data from 927 HC subjects (18-94 years of age) and applied the models to the test sets including 648 patients with SZ (18-66 years of age), 185 patients with BD (18-64 years of age), and 990 HC subjects (17-68 years of age), estimating the brain age for each participant. Group differences were assessed using linear models, accounting for age, sex, and scanner. A meta-analytic framework was applied to assess the heterogeneity and generalizability of the results.RESULTS: Tenfold cross-validation revealed high accuracy for all models. Compared with HC subjects, the model including all feature sets significantly overestimated the age of patients with SZ (Cohen's d = -0.29) and patients with BD (Cohen's d = 0.18), with similar effects for the other models. The meta-analysis converged on the same findings. Fractional anisotropy-based models showed larger group differences than the models based on other DTI-derived metrics.CONCLUSIONS: Brain age prediction based on DTI provides informative and robust proxies for brain white matter integrity. Our results further suggest that white matter aberrations in SZ and BD primarily consist of anatomically distributed deviations from expected lifespan trajectories that generalize across cohorts and scanners.
|
|
